Treatment of chronic viral hepatitis with nitazoxanide and second generation thiazolides (Q24657539)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Treatment of chronic viral hepatitis with nitazoxanide and second generation thiazolides	scientific article

Statements

instance of

scholarly article

0 references

review article

1 reference

stated in

Europe PubMed Central

title

Treatment of chronic viral hepatitis with nitazoxanide and second generation thiazolides (English)

0 references

main subject

viral hepatitis

1 reference

based on heuristic

inferred from title

author name string

Emmet B Keeffe

series ordinal

1

0 references

Jean-François Rossignol

series ordinal

2

0 references

language of work or name

English

0 references

publication date

21 April 2009

0 references

published in

World Journal of Gastroenterology

0 references

volume

15

0 references

issue

15

0 references

page(s)

1805-8

0 references

cites work

Potential for Hepatitis C Virus Resistance to Nitazoxanide or Tizoxanide

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670405

retrieved

7 April 2017

Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670405

retrieved

7 April 2017

Nitazoxanide: a review of its use in the treatment of gastrointestinal infections

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670405

retrieved

7 April 2017

Thiazolides: a new class of drugs for the treatment of chronic hepatitis B and C.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670405

retrieved

28 September 2017

Clinical trial: randomized, double-blind, placebo-controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670405

retrieved

28 September 2017

Improved virologic response in chronic hepatitis C genotype 4 treated with nitazoxanide, peginterferon, and ribavirin

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670405

retrieved

28 November 2018

Identifiers

DOI

10.3748/WJG.15.1805

0 references

Fatcat ID

release_cv44hxjur5drhdklzxuhfja3xy

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/cv44hxjur5drhdklzxuhfja3xy

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

2670405

0 references

PubMed publication ID

19370775

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24657539&oldid=1838621405"